Diagnosing Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPNs) are a group of slow-growing blood cancers characterized by the overproduction of abnormal red blood cells, white blood cells, or platelets in the bone marrow. To diagnose MPNs, several examinations, screening tests, and procedures are used. Specialists involved in diagnosing MPNs may include hematologists and oncologists. Here's a breakdown of the different tests and procedures used:
- Physical exam and health history: A healthcare professional will conduct a physical exam to check for general signs of health and any specific indicators of MPNs, such as an enlarged spleen or liver. They will also ask about your health habits, past illnesses, and treatments.
- Complete blood count (CBC) with differential: This test involves drawing a blood sample to measure various components, including red blood cells, white blood cells, platelets, and hemoglobin levels. Abnormalities in these counts can indicate the presence of MPNs.
- Peripheral blood smear: In this procedure, a sample of blood is examined under a microscope to assess the presence of blast cells (immature blood cells), types of white blood cells, platelet count, and any changes in the shape of blood cells.
- Bone marrow aspiration and biopsy: To obtain a sample of bone marrow for analysis, a doctor uses a long, thin needle to extract bone marrow from the hipbone or breastbone. The samples are then examined under a microscope to look for abnormal cells. This procedure is crucial for confirming a diagnosis of MPNs.
- Cytogenetic analysis: This laboratory test counts and checks the chromosomes in bone marrow or blood samples for any changes or abnormalities. Certain chromosomal changes can be indicative of cancer, including MPNs.
- Blood chemistry studies: This test measures the levels of specific substances released into the blood by organs and tissues in the body. Abnormal levels may suggest the presence of MPNs.
In addition to these diagnostic tests, specialists may order additional examinations or imaging studies to determine the type, severity, or stage of MPNs:
- Genetic testing: This test checks for specific genetic mutations associated with MPNs.
- Imaging studies: Doctors may recommend imaging studies such as X-rays, ultrasounds, CT scans, or MRI scans to get a better understanding of the extent and location of any abnormalities.
These examinations and tests are essential in diagnosing myeloproliferative neoplasms and determining their type, severity, or stage. It's important to consult with a healthcare professional who can guide you through this process and interpret the results accurately.